Endometriosis and angiogenesis

Minerva Ginecologica

Volumn 60, Issue 3, 2008, Pages 245-254

  May, K ^a   Becker, C M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Endometriosis; Endometriosis, therapeutics; Neovascularization, physiologic

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; CYCLOOXYGENASE 2 INHIBITOR; ENDOSTATIN; GONADORELIN; ORAL CONTRACEPTIVE AGENT; VASCULOTROPIN INHIBITOR;

ANALGESIA; ANGIOGENESIS; ENDOMETRIOSIS; ENDOMETRIUM; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; IMPLANT; LAPAROSCOPY; MENSTRUAL CYCLE; REVIEW; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; CYCLOOXYGENASE 2 INHIBITORS; ENDOMETRIOSIS; ENDOSTATINS; FEMALE; HUMANS; LAPAROSCOPY; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48649083029     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005;20:2698-704.
2. Sampson J. Peritoneal endometriosis due to the menstrual dissemination of endothelial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-69.
3. Klagsbrun M, Moses MA. Molecular angiogenesis. Chem Biol 1999;6:R217-224.
4. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63.
5. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003;314:15-23.
6. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4.
7. Ausprunk DH, Knighton DR, Folkman J. Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev Biol 1974;38:237-48.
8. Burri PH, Hlushchuk R, Djonov V. Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn 2004;231:474-88.
9. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
10. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H et al. VEGF contributes to postnatal neo vascularization by mobilizing bone marrow-derived endothelial progenitor cells. The EMBO Journal 1999;18:3964-72.
11. Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocr Rev 2006;27:17-46.
12. Rogers PA, Gargett CE. Endometrial angiogenesis. Angiogenesis 1998;2:287-94.
13. Gargett CE, Lederman FL, Lau TM, Taylor NH, Rogers PA. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum Reprod 1999 14:2080-8.
14. Goodger AM, Rogers PA. Endometrial endothelial cell proliferation during the menstrual cycle. Hum Reprod 1994;9:399-405.
15. Nayak NR, Brenner RM. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J Clin Endocrinol Metab 2002;87:1845-55.
16. Gambino LS, Wreford NG, Bertram JF, Dockery P, Lederman F, Rogers PA. Angiogenesis occurs by vessel elongation in proliferative phase human endometrium. Hum Reprod 2002;17:1199-206.
17. Fraser HM, Wilson H, Silvestri A, Morris KD, Wiegand SJ. the role of vascular endothelial growth factor and estradiol in the regulation of endometrial angiogenesis and cell proliferation in the Marmoset. Endocrinology 2008. [Epub ahead of print]
18. Print C, Valtola R, Evans A, Lessan K, Malik S, Smith S. Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome. Hum Reprod 2004;19:2356-66.
19. Nayak NR, Critchley HO, Slayden OD, Menrad A, Chwalisz K, Baird DT et al. Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J Clin Endocrinol Metab 2000;85:3442-52.
20. Fraser HM, Lunn SF. Angiogenesis and its control in the female reproductive system. Br Med Bull 2000;56:787-97.
21. Mints M, Jansson M, Sadeghi B, Westgren M, Uzunel M, Hassan M et al. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Hum Reprod 2008;23:139-43.
22. Nap AW, Groothuis PG, Demir AY, Maas JW, Dunselman GA, de Goeij AF et al. Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane. Hum Reprod 2003;18:30-4.
23. Folkman J, Kalluri R 2003 Tumor angiogenesis. In: Kufe DW, editor. Cancer Medicine. Ontario, Canada: Decker, B.C.; 161-94.
24. Becker CM, D'Amato RJ. 2007 Angiogenesis and antiangiogenic therapv in endometriosis. Microvasc Res 2007;74:121-30.
25. Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A et al. 2008 2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor-1{alpha} and Suppresses Growth of Lesions in a Mouse Model of Endometriosis. Am J Pathol 2008;172:534-44.
26. Halme et al. 1984
27. Koninckx 1994.
28. Oosterlynck DJ, Meuleman C, Sobis H, Vandeputte M, Koninckx PR. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril 1993;59:778-82.
29. Na YJ, Yang SH, Baek DW, Lee DH, Kim KH, Choi YM et al. Effects of peritoneal fluid from endometriosis patients on the release of vascular endothelial growth factor by neutrophils and monocytes. Hum Reprod 2006;21:1846-55.
30. McLaren J, Prentice A, Charnock-Jones DS, Smith SK. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11:220-23.
31. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. The J Clin Invest 1996;98:482-9.
32. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 1999;13:9-22.
33. Meduri G, Bausero P, Perrot-Applanat M. Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle. Biol Reprod 2000;62:439-47.
34. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006;312:549-60.
35. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hvpoxia-initiated angiogenesis. Nature 1992;359:843-5.
36. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A 1991;88:5680-4.
37. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995;92:5510-4.
38. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270:1230-7.
39. Kressin P, Wolber EM, Wodrich H, Meyhofer-Malik A, Buchweitz O, Diedrich K et al. Vascular endothelial growth factor mRNA in eutopic and ectopic endometrium. Fertil Steril 2001;76:1220-4.
40. Fakih H, Baggett B, Holtz G, Tsang KY, Lee JC, Williamson HO. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 1987;47:213-7.
41. Lebovic DI, Bentzien F, Chao VA, Garrett EN, Meng YG, Taylor RN. Induction of an angiogenic phenotype in endometriotic stromal cell cultures bv interieukin-1beta. Mol Hum Reprod 2000;6:269-75.
42. Rossi M, Sharkey AM, Vigano P, Fiore G, Furlong R, Florio P et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction 2005;130:721-9.
43. Gilabert-Estelles J, Ramon LA, Espana F, Gilabert J, Vila V, Reganon E et al. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 2007;22:2120-7.
44. Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 1998;58:1395-9.
45. Grummer R, Schwarzer F, Bainczyk K, Hess-Stumpp H, Regidor PA, Schindler AE et al. Peritoneal endometriosis: validation of an in-vivo model. Hum Reprod 2001;16:1736-43.
46. Becker CM, Wright RD, Satchi-Fainaro R, Funakoshi T, Folkman J, Kung AL et al. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Am J Pathol 2006;168:2074-84.
47. Eggermont J, Donnez J, Casanas-Roux F, Scholtes H, Van Langendonckt A. Time course of pelvic endometriotic lesion revascularization in a nude mouse model. Fertil Steril 2005;84:492-9.
48. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81:174-9.
49. Zeitoun KM, Bulun SE. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 1999;72:961-9.
50. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 1998;83:4474-80.
51. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci U S A 2000;97:10972-7.
52. Chishima F, Hayakawa S, Sugita K, Kinukawa N, Aleemuzzaman S, Nemoto N et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 2002;48:50-6.
53. Van Voorhis BJ, Huettner PC, Clark MR, Hill JA. Immunohistochemical localization of prostaglandin H synthase in the female reproductive tract and endometriosis. Am J Obstet Gynecol 1990;163:57-62.
54. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000;105:1589-94.
55. Tamura M, Deb S, Sebastian S, Okamura K, Bulun SE. Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. Fertil Steril 2004;81:1351-6.
56. Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997;82:600-6.
57. Olive DL, Pritts EA. Treatment of endometriosis. New Engl J Med 2001;345:266-75.
58. Marx J. Cancer. Encouraging results for second-generation antiangiogenesis drugs. Science 2005;308:1248-9.
59. Klauber N, Rohan RM, Flynn E, D'Amato RJ. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med 1997;3:443-6.
60. Ratner M. Genentech discloses safety concerns over Avastin. Nature Biotechnol 2004;22:1198.
61. Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. New Engl J Med 2003;349:427-34.
62. McBride WG. Thalidomide and congenital abnormalities. Lancet 1961;278:1358.
63. Becker CM, Sampson DA, Rupnick MA, Rohan RM, Efstathiou JA, Short SM et al. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil Steril 2005;84(Suppl 2):1144-55.
64. Becker CM, Sampson DA, Short SM, Javaherian K, Folkman J, D'Amato RJ. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. Fertil Steril 2006;85:71-7.
65. Folkman J. Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action. Exp Cell Res 2006;312:594-607.
66. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003;88:2889-99.
67. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
68. Abdollahi A, Hahnfeldt P, Maercker C, Grone HJ, Debus J, Ansorge W et al. Endostatin's antiangiogenic signaling network. Mol Cell 2004;13:649-63.
69. Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004;89:1089-95.
70. Kim JG, Kim JY, Jee BC, Suh CS, Kim SH, Choi YM. Association between endometriosis and polymorphisms in endostatin and vascular endothelial growth factor and their serum levels in Korean women. Fertil Steril 2008;89:243-5.
71. Ling Y, Yang Y, Lu N, You QD, Wang S, Gao Y et al. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells. Biochem Biophys Res Commun 2007;361:79-84.
72. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
73. Veitonmaki N, Cao R, Wu LH, Moser TL, Li B, Pizzo SV et al. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis. Cancer Res 2004;64:3679-86.
74. Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D et al. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 2005;7:251-61.
75. Dabrosin C, Gyorffy S, Margetts P, Ross C, Gauldie J. Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. Am J Pathol 2002;161:909-18.
76. Matsuzaki S, Canis M, Darcha C, Dallel R, Okamura K, Mage G. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 2004;82:1609-15.
77. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. New Engl J Med 2005;352:1092-102.